LB-5 | Update from the Safety Assessment of Femoropopliteal Endovascular treatment with PAclitaxel-coated Devices (SAFE-PAD) Study

Abstract

Paclitaxel-coated peripheral devices have been associated with increased mortality, yet this harm signal has not been replicated outside of meta-analyses of small trials. The SAFE-PAD Study (NCT04496544) was created with the FDA to provide a longitudinal safety assessment of these devices, with follow-up data now surpassing 6 years.